Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Mirum Pharmaceuticals (MIRM) FCF Margin: 2020-2025

Historic FCF Margin for Mirum Pharmaceuticals (MIRM) over the last 5 years, with Sep 2025 value amounting to 29.69%.

  • Mirum Pharmaceuticals' FCF Margin rose 2548.00% to 29.69% in Q3 2025 from the same period last year, while for Sep 2025 it was 9.39%, marking a year-over-year increase of 1011.00%. This contributed to the annual value of 2.77% for FY2024, which is 4089.00% up from last year.
  • Latest data reveals that Mirum Pharmaceuticals reported FCF Margin of 29.69% as of Q3 2025, which was up 218.47% from 9.32% recorded in Q2 2025.
  • Mirum Pharmaceuticals' FCF Margin's 5-year high stood at 745.73% during Q1 2021, with a 5-year trough of -1,056.41% in Q4 2021.
  • Over the past 3 years, Mirum Pharmaceuticals' median FCF Margin value was -5.12% (recorded in 2024), while the average stood at -10.51%.
  • As far as peak fluctuations go, Mirum Pharmaceuticals' FCF Margin tumbled by 1,189,432bps in 2021, and later soared by 93,273bps in 2022.
  • Over the past 5 years, Mirum Pharmaceuticals' FCF Margin (Quarterly) stood at -1,056.41% in 2021, then soared by 93,273bps to -123.67% in 2022, then surged by 9,978bps to -23.89% in 2023, then surged by 1,877bps to -5.12% in 2024, then surged by 2,548bps to 29.69% in 2025.
  • Its FCF Margin was 29.69% in Q3 2025, compared to 9.32% in Q2 2025 and -1.79% in Q1 2025.